An additional recall has been issued on August 5th 2019: Abbott (Formerly St. Jude Medical Inc.), Recalls Ellipse Implantable Cardioverter Defibrillators Due to Exposed Aluminum Wires That May Prevent Defibrillation Therapy The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries [...]
FDA orders manufacturers of surgical mesh intended to treat pelvic organ prolapse, to stop distribution immediately
On April 16, 2019, the FDA ordered all manufacturers of surgical mesh intended for transvaginal repair of anterior compartment prolapse (cystocele) to stop selling and distributing their products immediately. The FDA has determined that the manufacturers, Boston Scientific and Coloplast, have not demonstrated reasonable assurance of safety and effectiveness for these devices, which is the premarket standard [...]
FDA updates on angiotensin II receptor blocker (ARB) recalls including valsartan, losartan and irbesartan IMPORTANT: Medications containing only amlodipine or hydrochlorothiazide (HCTZ) are not being recalled. Manufacturers are recalling medications containing amlodipine in combination with valsartan or losartan, and medications containing hydrochlorothiazide HCTZ in combination with valsartan or losartan. […]
FDA has concluded there is an increased risk of death with Uloric (febuxostat) compared to another gout medicine, allopurinol. This conclusion is based on our in-depth review of results from a safety clinical trial that found an increased risk of heart-related death and death from all causes with Uloric.
A U.S. Food and Drug Administration (FDA) review found that fluoroquinolone antibiotics can increase the occurrence of rare but serious events of ruptures or tears in the main artery of the body, called the aorta. These tears, called aortic dissections, or ruptures of an aortic aneurysm can lead to dangerous bleeding or even death.
Torrent Pharmaceuticals Limited is voluntarily recalling 2 lots of Losartan potassium tablets, USP to the consumer level due to the detection of trace amounts of a probable human carcinogen.
UPDATE – More blood pressure medications added to what is NOW a global recall for potential cancer risk: [11/29/2018] Teva Pharmaceuticals has launched a voluntary recall into two drugs used to treat high blood pressure as yet more medications face concerns over a possible cancer risk. In a statement from Teva posted [...]
NYC hospitals continues their poor performance on Leapfrog's hospital safety grades list, with most earning Cs or Ds. Healthcare providers in all five boroughs once again performed poorly in Leapfrog's* Fall 2018 ratings for hospital safety. More than 50% of 44 New York City facilities graded earned a C grade and only three facilities managed a B [...]
RGLZ Trial Attorney Tom Valet Wins $8,000,000.00 Verdict After a Brooklyn Jury Finds the NYC Transit Authority 100% at Fault. After a heavy snowstorm RGLZ’s client fell down an exterior subway staircase injuring his back, neck and shoulder. He required 3 surgeries, 2 to his spine and 1 to his [...]
On November 16th 2017, a federal jury in Dallas, TX told Johnson & Johnson and their subsidiary DePuy that they need to pay six patients a total of $247 million due to hip implants that turned out to be defective. The verdict came as a result of finding that the hip implants used a metal [...]